News
The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.
16hon MSN
Delta passengers were stranded on a tiny island in the middle of the Atlantic for 29 hours after midair engine trouble ...
16hon MSN
Maya Ortiz of North Reading is organizing “Trotting In Teal,” an awareness/fundraising event for ovarian cancer that will be ...
A sunny day at Pumpkin Ridge Golf Club set the stage for the 12th annual Dunn's Duffers Charity Golf Tournament, organized by ...
Kuick Research Report highlights ongoing Clinical Development Technology platforms In Recent Research Study On KIF18A ...
17h
Medpage Today on MSNBiomarker Testing in Advanced Cancer Still Lags Behind Guideline RecommendationsOverall, 35% of patients' records had evidence of comprehensive genomic profiling (CGP). The rate increased modestly from 32% at the beginning of the study period to 39% at the end, reported Stacey ...
The published data showed that the combination of avutometinib plus defactinib demonstrated a confirmed overall response rate of 31% in all patients with recurrent low-grade serous ovarian cancer ...
20h
Woman's World on MSNPierce Brosnan & Keely Shaye Brosnan: Their Sweet Love Story of 30+ YearsNot everyone gets a second chance at love-but Irish actor Pierce Brosnan, 72, counts his lucky stars that he found magic ...
Bayer receives UK MHRA approval for Lynkuet to treat moderate to severe vasomotor symptoms associated with menopause: Berlin Saturday, July 12, 2025, 10:00 Hrs [IST] Bayer announc ...
A woman has published a book about her experience of being diagnosed with three rare cancers. Colette Swindells was first diagnosed with gallbladder cancer in 2016 at the age of 46. After surgery and ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results